Lundbeck
HLUN-B.CO
#2810
Rank
โ‚น365.61 B
Marketcap
โ‚น380.17
Share price
-5.43%
Change (1 day)
-5.20%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): โ‚น29.01

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is โ‚น30.24. In 2022 the company made an earnings per share (EPS) of โ‚น22.99 a decrease over its 2021 EPS that were of โ‚น51.64.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น29.0126.17%
2022โ‚น22.99-55.47%
2021โ‚น51.64-51.83%
2020โ‚น107.20-28.01%
2019โ‚น148.91-44.08%
2018โ‚น266.2851.94%
2017โ‚น175.25126.64%
2016โ‚น77.33-120.84%
2015-โ‚น371.075622.18%
2014-โ‚น6.48-110.03%
2013โ‚น64.63-28.08%
2012โ‚น89.86-52.1%
2011โ‚น187.60-1.31%
2010โ‚น190.1015.61%
2009โ‚น164.43